Abstract:In this small group of patients showing CMR evidence of significant myocardial inducible perfusion defect and viability, CTO recanalization reduces ischemic burden, favors reverse remodeling, and ameliorates quality of life.
“…All three mentioned studies [9–11] showed that the improvement in regional wall thickening after a successful CTO-PCI was indirectly related to the transmurality of LGE in a myocardial segment. More recently and in consonance with our findings, Bucciarelli-Ducci et al [12] reported a significant improvement in LVESV and LVEF after successful CTO-PCI in a group of 32 patients with preserved LVEF showing CMR evidence of myocardial viability and ischemia. Other than older studies assessing LVEF with contrast ventriculography [13, 14], Valenti et al published the only large study to date showing improved LVEF after successful CTO recanalization [15].…”
Section: Discussionsupporting
confidence: 92%
“…The proportion of patients with history of previous myocardial infarction and the high prevalence of classic cardiovascular risk factors in this cohort are consistent with previous published data [22, 23]. Improvement in angina status after CTO-PCI has also been shown in previous studies in patients with preserved LVEF [7, 8, 12, 16, 18]. …”
Section: Discussionsupporting
confidence: 91%
“…Pujadas et al [7] showed a reduction in the number of ischemic segments in 33 patients who underwent successful PCI of a single CTO. Similarly, Bucciarelli-Ducci et al [12] described a complete or almost complete resolution of perfusion defect after CTO-PCI along with an increased myocardial perfusion reserve in the CTO territory. It is worth mentioning that in both studies LVEF was preserved in most of the patients before the PCI procedure and mean necrotic mass was much lower than in the present study (6 and 11 g vs. 22 g).…”
BackgroundChronic total occlusion percutaneous coronary intervention (CTO-PCI) can improve angina and left ventricular ejection fraction (LVEF). These benefits were not assessed in populations with heart failure with reduced ejection fraction (HFrEF). We studied the effect of CTO-PCI on left ventricular function and clinical parameters in patients with HFrEF.MethodsUsing cardiovascular magnetic resonance (CMR), we studied 29 patients with HFrEF and evidence of viability and/or ischemia in the territory supplied by a CTO who were successfully treated with CTO-PCI. In patients with multi-vessel disease, non-CTO PCI was also performed. Imaging parameters, clinical status, and brain natriuretic peptide (BNP) levels were evaluated before and 6 months after CTO-PCI.ResultsA decrease in left ventricular end-systolic volume (160 ± 54 ml vs. 143 ± 58 ml; p = 0.029) and an increase in LVEF (31.3 ± 7.4 % vs. 37.7 ± 8 %; p < 0.001) were observed. There were no differences in LVEF improvement between patients who underwent non-CTO PCI (n = 11) and those without this intervention (n = 18); (p = 0.73). The number of segments showing perfusion defects was significantly reduced (0.5 ± 1 vs. 0.2 ± 0.5; p = 0.043). Angina (p = 0.002) and NYHA functional class (p = 0.004) improved, and BNP levels decreased (p = 0.004) after CTO-PCI.ConclusionsIn this group of patients with HFrEF showing CMR evidence of viability and/or ischemia within the territory supplied by the CTO, an improvement in ejection fraction, left ventricular end-systolic volume and ischemia burden was observed after CTO-PCI. Clinical and laboratory parameters also improved.Trial registrationClinicalTrials.gov NCT02570087. Registered 6 October 2015.
“…All three mentioned studies [9–11] showed that the improvement in regional wall thickening after a successful CTO-PCI was indirectly related to the transmurality of LGE in a myocardial segment. More recently and in consonance with our findings, Bucciarelli-Ducci et al [12] reported a significant improvement in LVESV and LVEF after successful CTO-PCI in a group of 32 patients with preserved LVEF showing CMR evidence of myocardial viability and ischemia. Other than older studies assessing LVEF with contrast ventriculography [13, 14], Valenti et al published the only large study to date showing improved LVEF after successful CTO recanalization [15].…”
Section: Discussionsupporting
confidence: 92%
“…The proportion of patients with history of previous myocardial infarction and the high prevalence of classic cardiovascular risk factors in this cohort are consistent with previous published data [22, 23]. Improvement in angina status after CTO-PCI has also been shown in previous studies in patients with preserved LVEF [7, 8, 12, 16, 18]. …”
Section: Discussionsupporting
confidence: 91%
“…Pujadas et al [7] showed a reduction in the number of ischemic segments in 33 patients who underwent successful PCI of a single CTO. Similarly, Bucciarelli-Ducci et al [12] described a complete or almost complete resolution of perfusion defect after CTO-PCI along with an increased myocardial perfusion reserve in the CTO territory. It is worth mentioning that in both studies LVEF was preserved in most of the patients before the PCI procedure and mean necrotic mass was much lower than in the present study (6 and 11 g vs. 22 g).…”
BackgroundChronic total occlusion percutaneous coronary intervention (CTO-PCI) can improve angina and left ventricular ejection fraction (LVEF). These benefits were not assessed in populations with heart failure with reduced ejection fraction (HFrEF). We studied the effect of CTO-PCI on left ventricular function and clinical parameters in patients with HFrEF.MethodsUsing cardiovascular magnetic resonance (CMR), we studied 29 patients with HFrEF and evidence of viability and/or ischemia in the territory supplied by a CTO who were successfully treated with CTO-PCI. In patients with multi-vessel disease, non-CTO PCI was also performed. Imaging parameters, clinical status, and brain natriuretic peptide (BNP) levels were evaluated before and 6 months after CTO-PCI.ResultsA decrease in left ventricular end-systolic volume (160 ± 54 ml vs. 143 ± 58 ml; p = 0.029) and an increase in LVEF (31.3 ± 7.4 % vs. 37.7 ± 8 %; p < 0.001) were observed. There were no differences in LVEF improvement between patients who underwent non-CTO PCI (n = 11) and those without this intervention (n = 18); (p = 0.73). The number of segments showing perfusion defects was significantly reduced (0.5 ± 1 vs. 0.2 ± 0.5; p = 0.043). Angina (p = 0.002) and NYHA functional class (p = 0.004) improved, and BNP levels decreased (p = 0.004) after CTO-PCI.ConclusionsIn this group of patients with HFrEF showing CMR evidence of viability and/or ischemia within the territory supplied by the CTO, an improvement in ejection fraction, left ventricular end-systolic volume and ischemia burden was observed after CTO-PCI. Clinical and laboratory parameters also improved.Trial registrationClinicalTrials.gov NCT02570087. Registered 6 October 2015.
“…Thirty‐four observational studies [including two abstracts ] with a total of 2804 patients met our inclusion criteria . Cardiac magnetic resonance imaging (CMR) was used to assess LVEF in nine studies while echocardiography was used in 10 studies . Other studies used left ventriculography or nuclear imaging, or did not specify the method used for assessing LVEF .…”
Successful CTO PCI is associated with a statistically significant improvement in LV ejection fraction and decrease in LV end-systolic volume, that may reflect a beneficial effect of CTO recanalization on LV remodeling. The clinical implications of these findings warrant further investigation.
“…Regional myocardial function, measured as segmental wall thickening (SWT), improved in segments with a transmural extent of infarction (TEI) of <75%, and was unchanged in patients with TEI ≥75%. A study of 50 consecutive patients with a CTO who underwent contrast enhanced CMR showed that 32 patients (64%) had inducible ischemia and myocardial viability within the CTO territory (12). These 32 patients underwent a second CMR at 3 months after CTO PCI.…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.